Latest Stock Market News

Indian markets are likely to open higher on Tuesday, tracking strong global cues. Nifty Futures closed up 0.68% at 24,567 on Monday. FPI and DII inflows remained positive. Options data suggests a trading range of 24,000–25,000. Analysts recommend buying stocks like HPCL, Shriram Finance, NBCC, and Aptech for short-term gains, with Nifty support seen at 24,200.

Axis Securities is optimistic about eight large-cap stocks. These stocks have the potential to rise up to 40%. The list includes SBI, ICICI Bank, and HDFC Bank. Shriram Finance and Bharti Airtel are also on the list. Axis Securities has provided target prices for each stock. Varun Beverages, Hero MotoCorp and DMart are also expected to give good returns.

ICICI Securities has a Hold call on Varun Beverages, maintaining a target price of Rs 500. The company s financials for Q1 2025 show a significant increase in total income and net profit. Despite positive growth prospects, the current valuation limits upside potential, leading to the Hold recommendation based on DCF valuation.

Several Indian companies are delaying their initial public offerings. This is due to weak investor sentiment and global economic uncertainty. Avanse Financial and Anthem Biosciences are among those postponing plans. Geopolitical tensions and global trade frictions are contributing factors. The market debut of Ather Energy will be a test of investor appetite.

The rupee weakened against the US dollar. This happened due to a stronger dollar index and weaker Asian currencies. Geopolitical tensions between India and Pakistan also affected investor sentiment. Crude oil prices and foreign fund inflows offered some support. Markets are reacting to potential policy changes. The rupee s movement is expected to be volatile. Sensex and Nifty also experienced declines.

Indian pharmaceutical stocks experienced a significant decline. This followed US President Donald Trump s executive order. The order aims to boost domestic drug production in the United States. Concerns arose about potential disruptions for Indian drug exporters. These exporters heavily rely on the US market. The Nifty Pharma index saw a drop. Companies like Lupin, Aurobindo Pharma, and Cipla faced losses.

Gold prices surged on Tuesday due to concerns over President Trump s proposed tariffs, increasing safe-haven demand. Investors are keenly awaiting the Federal Reserve s policy meeting for insights into future rate adjustments, especially with the current rate held steady since last December. Spot gold rose significantly, alongside silver and other metals, reflecting market uncertainty.

When the RSI value crosses above 50 from below, it signals that the Relative Strength Index (RSI) is rising, indicating strengthening momentum in the stock s price. This suggests a potential upward trend.

Explore the promising landscape of India s defense sector, driven by strategic government initiatives and robust growth potential. Discover key players and their performance metrics as the sector gears up for a transformative era.

The Nifty Pharma index was trading 0.88 per cent down at 21585.05.